One study using a mouse model of lung adenocarcinoma demonstrated that the LNME skews tumour antigen-specific CD4+ differentiation into regulatory T cells, thus promoting tumour immune escape [26]. This evidence concerns the gene CD4 and lung adenocarcinoma.